Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126390531 | 12639053 | 1 | I | 20160531 | 20140912 | 20160809 | 20160809 | PER | US-ASTRAZENECA-2014SE71434 | ASTRAZENECA | 31569.00 | DY | M | Y | 107.00000 | KG | 20160810 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126390531 | 12639053 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | AM140007 | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||
| 126390531 | 12639053 | 2 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 4 | MG | 0 | 2 | MG | /wk | ||||||
| 126390531 | 12639053 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 10.0MG UNKNOWN | 0 | 10 | MG | |||||||||
| 126390531 | 12639053 | 4 | C | LOSARTAN POTASSIUM + HCTZ | HYDROCHLOROTHIAZIDELOSARTAN | 1 | 1DF=125-25 UNIT NOS | 0 | |||||||||||
| 126390531 | 12639053 | 5 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | 30.0MG UNKNOWN | 0 | 30 | MG | |||||||||
| 126390531 | 12639053 | 6 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | 50.0MG UNKNOWN | 0 | 50 | MG | BID | ||||||||
| 126390531 | 12639053 | 7 | C | METOPROLOL. | METOPROLOL | 1 | 25.0MG UNKNOWN | 0 | 25 | MG | |||||||||
| 126390531 | 12639053 | 8 | C | VITRON-C | 2 | 0 | |||||||||||||
| 126390531 | 12639053 | 9 | C | COLACE | DOCUSATE SODIUM | 1 | 0 | 100 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126390531 | 12639053 | 1 | Type 2 diabetes mellitus |
| 126390531 | 12639053 | 2 | Type 2 diabetes mellitus |
| 126390531 | 12639053 | 5 | Type 2 diabetes mellitus |
| 126390531 | 12639053 | 6 | Type 2 diabetes mellitus |
| 126390531 | 12639053 | 8 | Anaemia |
| 126390531 | 12639053 | 9 | Faeces soft |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126390531 | 12639053 | Diarrhoea | |
| 126390531 | 12639053 | Drug administration error | |
| 126390531 | 12639053 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126390531 | 12639053 | 1 | 2016 | 0 | ||
| 126390531 | 12639053 | 2 | 20160523 | 0 |